Related Experiment Video
Updated: Apr 12, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Comparative Effectiveness of Medical Therapy, Supervised Exercise, and Revascularization for Patients With
Sreekanth Vemulapalli1,2, Rowena J Dolor2,3,4, Vic Hasselblad4
1Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Supervised exercise significantly improved walking distance for intermittent claudication (IC) patients compared to usual care. However, evidence is insufficient to determine the superiority of exercise, medical therapy, or revascularization for improving quality of life.
Area of Science:
- Vascular Medicine
- Exercise Physiology
- Interventional Cardiology
Background:
- Limited data exist on comparing medical therapy, supervised exercise, and revascularization for intermittent claudication (IC).
- Improving walking ability and quality of life are key goals for IC patients.
Purpose of the Study:
- To compare the effectiveness of exercise training, medications, endovascular intervention, and surgical revascularization.
- To evaluate outcomes including functional capacity, quality of life, and mortality in IC patients.
Main Methods:
- Systematic literature search of PubMed, EMBASE, and Cochrane Database (1995-2012).
- Meta-analyses of direct comparisons, supplemented by mixed-treatment analyses.
- Inclusion of 35 studies with 7475 patients with IC.
Main Results:
- Supervised exercise training improved maximal walking distance (150m) and initial claudication distance (39m) versus usual care.
- All treatments improved quality of life (SF-36 physical functioning) compared to usual care, with no significant differences between treatments.
- Insufficient safety data; no significant difference in all-cause mortality between modalities.
Conclusions:
- Current evidence is insufficient to declare treatment superiority for quality of life or walking parameters in IC.
- Further high-quality studies with standardized endpoints are needed to determine comparative effectiveness.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

